Ukujamelana neGout

Iingcebiso zokujongana nokuhlaselwa kunye nokukhusela ikusasa

Nangona i-gout ingalawulwa ngokubanzi kunye nokusetyenziswa kwezidakamizwa zokunciphisa i-acid kunye neminye imichiza yokulwa ne-anti-gout, kukho izixhobo zokulawula ukuziphendulela xa ungena kwiimeko zokuhlaselwa ngokuphindaphindiweyo okanye ezinzima. Zibandakanya yonke into ekulawuleni ukutya odlayo kumncinci, yonke imihla "izilungiso" ezinokukunceda ukukhusela ukuhlaselwa kwangomso.

Indlela yokuphila

Ngendlela efanayo nendlela yokuphila inokunyusa umngcipheko we-gout, ukuguqulwa kokuziphatha okungalunganga kunokunciphisa kakhulu ingozi. Kule nto, ezi zinto zintathu ezinobungozi ziquka ukutya kwakho, ubunzima bakho kunye notywala obutshisayo.

Ukutya

Iimpawu zeGout zivame ukubangelwa ukutya ukutya okunotye kwi-purine. I-Purine yinto ephilayo efumaneka kwiindawo ezininzi zokutya, ezithe zaphulwa ngumzimba, zibe yi- uric acid . I-acid yase-Uric yimbangela yesifo kunye notshaba kunoma ubani ohluphekayo.

Ukunciphisa umngcipheko wakho:

Ukuhla ukusinda

Ukugqithisa okanye ukugqithisa kwandisa umngcipheko wokuhlaselwa kwe-gout ngokunyusa ukuxhatshazwa kwe-insulin . Oku, kwenza ukuba izintso zakho zikwazi ukusebenza ngokuqhelekileyo, ezibangele ukuqokelela okungavamile kwe-uric acid egazini. Umngcipheko ukwanda ngakumbi xa unamafutha amaninzi kakhulu (ngesisu) ehambisana ne- syndrome ye-metabolic .

Ukunciphisa umngcipheko wakho, gxininisa ekulahlekelweni kwesisindo kuphela kodwa icebo lokuzilolonga lenzelwe ukutshisa ioli. Oku kudinga indlela encinci-kodwa-engqinelanayo , ngokufanelekileyo kunye nesondlo esinesifo sokutya kwisifo sengqondo kunye nomqeqeshi womzimba ohlangene nesifo se-metabolic syndrome.

Ukuqalisa isicwangciso somsebenzi ogqithiseleyo kunokubangela ukuba maxa wambi ukuhlaselwa kwe-gout, ngokukodwa xa ubeka uxinzelelo olungathandekanga kwiqela elichaphazelekayo okanye ufune ukungcola . Ngokufanayo, ukuzityhila ekudleni kokutya kungabangela iimpawu ngenxa yokunciphisa ngokukhawuleza kwamanani omzimba kunye nokwanda kwamaqabane kumazinga e-uric acid.

Utywala

Utywala bunengxaki njengoko ixabiso elincinci lingabangela i-uric acid. Kude, okubi kakhulu kwinqanaba libheriya elenziwe ngesilwanyana se-brewer, enye yemithombo ephezulu ye-purine.

Ukuba ulungele ukuhlaselwa kwe-gout, uphantse ufune ukuyeka ubhiya, kunye ne-whiskey kunye nazo zonke iindidi zobunxilisayo.

Kodwa, ngaba oku kuthetha ukuba ufanele ukuyeka ukusela ngokupheleleyo? Mhlawumbi ewe mhlawumbi akukho. Izifundo zihlala zihlukana nokuba iwayini idibaniswa nokuhlaselwa kwe-gout, kwaye abanye baye babonisa ukuba abafazi abanokuba bancitshiswa kakhulu kunabesilisa.

Ekubeni kungekhona wonke umntu obhekene ne-gout ngendlela efanayo, kufuneka usebenzise indlela efanelekileyo yokusela. Phakathi kwezinye izicwangciso zokuqwalasela:

Ngakolunye uhlangothi, ukuba unobandezelo obukhulu okanye obuphindaphindiweyo kwaye ufumanisa nzima ukuba ungaphuzi, thetha nodokotela wakho uze ubuze malunga neendlela zokonyango.

Usebenza

Ukuba ufumana uhlaselo olunzima lwe-gout, kukho amanyathelo okukhawuleza ongayithatha ukuphatha imeko yakho. Njengoko iimpawu zivama ukunyuka kwinxalenye yokuqala yokuhlaselwa, isenzo esheshayo sinokusindisa yonke intlungu kunye nentlungu.

Phakathi kwezinye ze-tips-to tips:

Xa kuthethwa oko, ukuba iimpawu zakho aziphuculanga emva kweeyure ezingama-48 okanye ezidlulileyo ngaphezulu kweveki, biza ugqirha wakho kwaye uhlele iseshoni.

Ukuba unyango, ungadinga ukwenza utshintsho kwipilisi yakho okanye uhlole ezinye iindlela zokuphila. Ukuba awukho, kusenokuba ixesha lokuhlola iindlela zokonyango .

> Imithombo:

> Richette, P. noBarden, T. "Gout." Lancet. 2010; 375 (9711): 318-28. INGXELO: 10.1016 / S0140-6736 (09) 60883-7.

> Neogi, T .; Chen, C; Niu, J. et al. "Utywala obuninzi kwaye uthayiphe umngcipheko wokuhlaselwa kwe-gout okuphindaphindiweyo: Ukufundisisa kwimeko ye-internet-based crossover." Am J Med. 2014; 127 (4): 311-318. INGXELO: 10.1016 / j.amjmed.2013.12.019.

> Zhang, Y; Chen, C; Choi, H. et al. "Ukutya kwe-Purine-rich riches and gout attacks." U- Ann Rheum Dis. 2012; 71 (9): 1448-53. INGXELO: 10.1136 / annrheumdis-2011-201215.